T2	No-of-participants 294 304	Twenty-six
T3	eligibility 305 343	women with nonmetastatic breast cancer
T4	intervention-participants 406 408	15
T5	intervention 379 387	exercise
T6	average-age 419 435	51.9 ± 9.8 years
T7	control 445 458	control group
T9	average-age 477 493	56.9 ± 7.0 years
T8	control-participants 464 466	11
T1	outcome-Measure 543 559	lactate sampling
T10	outcome-Measure 561 589	one-repetition maximum tests
T11	outcome-Measure 596 616	HADS-D questionnaire
T12	outcome-Measure 879 888	endurance
T13	outcome 933 953	strength performance
T14	outcome 1004 1019	quality of life
T15	outcome 1077 1091	adverse events
